{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:46:04Z","timestamp":1792464364940,"version":"4.5.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>With the growing incidence of multi-drug resistant organisms, delabelling incorrect antibiotic allergies has become an integral part of antimicrobial stewardship worldwide. For example, around 90% of penicillin allergy labels are found to be inaccurate following a full allergy work-up, which deprive patients the use of effective first-line penicillin antibiotics and increase the risk of antimicrobial resistance with the use of other extended spectrum non-penicillin antimicrobials. Significant numbers of adult and paediatric patients over time are labelled with multiple penicillin and non-penicillin antibiotic allergies often during inappropriate antimicrobial use, resulting in a label of \u201cmultiple antibiotic allergy\u201d. In contrast to delabelling penicillin allergy where oral direct provocation tests can be used for low-risk, mild reactions, and sensitivity\/specificity\/positive and negative predictive values of skin tests have been demonstrated, diagnostic tests for multiple antibiotic allergy often require the use of a combination of in-vivo and in-vitro tests across different antimicrobial classes for evaluation. Shared decision making with patients and informed consent are also needed when prioritising which drugs to delabel first, balancing the risks, benefits of testing vs. interim use of alternative antibiotics. Similar to delabelling penicillin allergy, the cost-effectiveness of delabelling multiple drug allergies is unknown.<\/jats:p>","DOI":"10.3389\/falgy.2023.1156137","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T06:46:47Z","timestamp":1678949207000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Delabelling multiple antibiotic allergy: Practical issues"],"prefix":"10.3389","volume":"4","author":[{"given":"Philip Hei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard Yu-Hor","family":"Thong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/all.13765","article-title":"Immune pathomechanism and classification of drug hypersensitivity","volume":"74","author":"Pichler","year":"2019","journal-title":"Allergy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e12190","DOI":"10.1002\/clt2.12190","article-title":"Characterization, epidemiology and risk factors of multiple drug allergy syndrome and multiple drug intolerance syndrome: a systematic review","volume":"12","author":"Jagpal","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1016\/j.jaip.2020.08.033","article-title":"Tackling the patient with multiple drug \u201callergies\u201d: multiple drug intolerance syndrome","volume":"8","author":"Guyer","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.anai.2011.11.006","article-title":"Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management","volume":"108","author":"Macy","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s40264-014-0236-x","article-title":"Multiple drug intolerance syndrome: a large-scale retrospective study","volume":"37","author":"Omer","year":"2014","journal-title":"Drug Saf"},{"key":"B6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1059321","DOI":"10.3389\/falgy.2022.1059321","article-title":"Differences in beta-lactam and penicillin allergy: beyond the west and focusing on Asia-Pacific","volume":"3","author":"Mak","year":"2022","journal-title":"Front Allergy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e204199","DOI":"10.1001\/jamanetworkopen.2020.4199","article-title":"Prevalence, incidence, and sensitization profile of beta-lactam antibiotic allergy in Hong Kong","volume":"3","author":"Li","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jaip.2019.03.015","article-title":"Identifying low-risk beta-lactam allergy patients in a UK tertiary centre","volume":"7","author":"Siew","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"02006-3","DOI":"10.1016\/j.anai.2022.12.023","article-title":"Penicillin allergy delabeling: opportunities for implementation and dissemination","author":"Samarakoon","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijid.2022.11.026","article-title":"The effectiveness of interventions that support penicillin allergy assessment and de-labelling of adult and paediatric patients by non-allergy specialists: a systematic review and meta-analysis","volume":"129","author":"Powell","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e063784","DOI":"10.1136\/bmjopen-2022-063784","article-title":"Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol","volume":"12","author":"Copaescu","year":"2022","journal-title":"BMJ Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jaip.2022.08.052","article-title":"Comparative effectiveness, safety, and real-world outcomes of a nurse-led, protocol-driven penicillin allergy evaluation from the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI)","volume":"11","author":"Kan","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11096-020-01226-7","article-title":"The role of a clinical pharmacist in spurious penicillin allergy: a narrative review","volume":"43","author":"Bhogal","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/cea.14217","article-title":"BSACI guideline for the set-up of penicillin allergy de-labelling services by non-allergists working in a hospital setting","volume":"52","author":"Savic","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"974138","DOI":"10.3389\/falgy.2022.974138","article-title":"Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) consensus statements for penicillin allergy testing by nonallergists","volume":"3","author":"Li","year":"2022","journal-title":"Front Allergy"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100640","DOI":"10.1016\/j.waojou.2022.100640","article-title":"Standards for practical intravenous rapid drug desensitization & delabeling: a WAO committee statement","volume":"15","author":"Alvarez-Cuesta","year":"2022","journal-title":"World Allergy Organ J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jaip.2020.09.010","article-title":"Safety, efficacy, and effectiveness of delabeling in patients with multiple drug allergy labels","volume":"9","author":"Vethody","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imj.15532","article-title":"Penicillin allergy delabeling program: an exploratory economic evaluation in the Australian context","volume":"53","author":"Brusco","year":"2023","journal-title":"Intern Med J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/ACI.0000000000000543","article-title":"Drug provocation testing: risk stratification is key","volume":"19","author":"Garvey","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"dlac116","DOI":"10.1093\/jacamr\/dlac116","article-title":"Improving antimicrobial stewardship with penicillin allergy testing: a review of current practices and unmet needs","volume":"4","author":"Mabilat","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"B22","doi-asserted-by":"publisher","first-page":"104611","DOI":"10.1016\/j.ijmedinf.2021.104611","article-title":"Automation of penicillin adverse drug reaction categorisation and risk stratification with machine learning natural language processing","volume":"156","author":"Inglis","year":"2021","journal-title":"Int J Med Inform"},{"key":"B23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.23750\/abm.v90i3-S.8166","article-title":"Chronic urticaria and drug hypersensitivity in children","volume":"90","author":"Mastrorilli","year":"2019","journal-title":"Acta Biomed"},{"key":"B25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4168\/aair.2023.15.1.32","article-title":"Chronic spontaneous urticaria in Hong Kong: clinical characteristics, real-world practice and implications for COVID-19 vaccination","volume":"15","author":"Kan","year":"2023","journal-title":"Allergy Asthma Immunol Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/all.12617","article-title":"Drug hypersensitivity in clonal mast cell disorders: ENDA\/EAACI position paper","volume":"70","author":"Bonadonna","year":"2015","journal-title":"Allergy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4168\/aair.2021.13.2.284","article-title":"Piperacillin-tazobactam allergies: an exception to usual penicillin allergy","volume":"13","author":"Wong","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.iac.2022.01.003","article-title":"Skin testing approaches for immediate and delayed hypersensitivity reactions","volume":"42","author":"Barbaud","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"B29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4168\/aair.2017.9.4.288","article-title":"In vitro diagnostic testing for antibiotic allergy","volume":"9","author":"Dona","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/ijms18061222","article-title":"The value of in vitro tests to DiminishDrug challenges","volume":"18","author":"Mayorga","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cea.14104","article-title":"Anti-tuberculous drug allergy: diagnostic challenges","volume":"52","author":"Tan","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/cea.14084","article-title":"Practical management of suspected hypersensitivity reactions to anti-tuberculosis drugs","volume":"52","author":"Bermingham","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"B33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jhin.2020.05.042","article-title":"Impact of penicillin allergy records on antibiotic costs and length of hospital stay: a single-centre observational retrospective cohort","volume":"106","author":"Powell","year":"2020","journal-title":"J Hosp Infect"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1186\/s12879-021-06794-1","article-title":"De-labelling penicillin allergy in acutely hospitalized patients: a pilot study","volume":"21","author":"Steenvoorden","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"584633","DOI":"10.3389\/fphar.2020.584633","article-title":"Analysis of the costs associated with the elective evaluation of patients labelled as allergic to beta-lactams or nonsteroidal antiinflamatory agents","volume":"11","author":"Sobrino-Garcia","year":"2020","journal-title":"Front Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1017\/ice.2020.1229","article-title":"The impact of antibiotic allergy labels on antibiotic exposure, clinical outcomes, and healthcare costs: a systematic review","volume":"42","author":"Krah","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"953117","DOI":"10.3389\/falgy.2022.953117","article-title":"Prevalence and impact of misdiagnosed drug allergy labels among patients with hereditary angioedema","volume":"3","author":"Wong","year":"2022","journal-title":"Front Allergy"},{"key":"B38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/ACI.0000000000000761","article-title":"Drug allergy management in the elderly","volume":"21","author":"Wong","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/diagnostics10110918","article-title":"Prevalence and impact of reported drug allergies among rheumatology patients","volume":"10","author":"Chan","year":"2020","journal-title":"Diagnostics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.12809\/hkmj208716","article-title":"Epidemiology and outcomes of geriatric and non-geriatric patients with drug allergy labels in Hong Kong","volume":"27","author":"Li","year":"2021","journal-title":"Hong Kong Med J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e13955","DOI":"10.1111\/tid.13955","article-title":"Antibiotic allergy labels in immunocompromised populations","volume":"24","author":"Waldron","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/cid\/cix244","article-title":"Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation","volume":"65","author":"Trubiano","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.anai.2022.05.011","article-title":"The role of the allergist in coronavirus disease 2019 vaccine allergy safety: a pilot study on a \u201chub-and-spoke\u201d model for population-wide allergy service","volume":"129","author":"Chiang","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.12932\/AP-110722-1410","article-title":"COVID-19 Vaccine Allergy Safety Track (VAS-Track) pathway: real-world outcomes on vaccination rates and antibody protection","author":"Chiang","year":"2023","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e001287","DOI":"10.1136\/rmdopen-2020-001287","article-title":"Cost assessment of health interventions and diseases","volume":"6","author":"Fautrel","year":"2020","journal-title":"RMD Open"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta16120","article-title":"A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen\u00ae for the treatment of bee and wasp venom allergy","volume":"16","author":"Hockenhull","year":"2012","journal-title":"Health Technol Assess"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20670","article-title":"ImmunoCAP\u00ae ISAC and microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis","volume":"20","author":"Westwood","year":"2016","journal-title":"Health Technol Assess"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17170","article-title":"A systematic review and cost-effectiveness analysis of specialist services and adrenaline auto-injectors in anaphylaxis","volume":"17","author":"Armstrong","year":"2013","journal-title":"Health Technol Assess"},{"key":"B49","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jaip.2022.10.037","article-title":"Addressing the challenges of penicillin allergy delabeling with electronic health records and mobile applications","volume":"11","author":"Powell","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/all.12929","article-title":"Drug allergy passport and other documentation for patients with drug hypersensitivity - an ENDA\/EAACI drug allergy interest group position paper","volume":"71","author":"Brockow","year":"2016","journal-title":"Allergy"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1156137\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T01:32:01Z","timestamp":1702085521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1156137\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":50,"alternative-id":["10.3389\/falgy.2023.1156137"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2023.1156137","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"article-number":"1156137"}}